Related Experiment Videos
Genetic markers of ventricular hypertrophy
1Minneapolis Heart Institute Foundation, Minnesota 55407, USA.
The American Journal of Cardiology
|March 20, 1997
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Unexpected ICD pulse generator failure due to electronic circuit damage caused by electrical overstress.
Pacing and clinical electrophysiology : PACE·2001
Hypertrophic cardiomyopathy with left ventricular apical diverticulum.
The American journal of cardiology·1996
Clinical results with nonthoracotomy ICD systems.
Pacing and clinical electrophysiology : PACE·1993
Electrocardiographic manifestations of the rapid recharge function of pulse generators after sensing.
Pacing and clinical electrophysiology : PACE·1988
The automatic implantable cardioverter-defibrillator. Clinical experience, complications, and follow-up in 25 patients.
Archives of internal medicine·1988
Aldosterone dysregulation in essential hypertension.
The American journal of cardiology·2026
Long-term Outcomes of Renal Function Following CTO PCI: Insights on Contrast Exposure.
The American journal of cardiology·2026
Early And Long-term Outcomes After DOAC Initiation In Hospitalized Patients With Newly Diagnosed Atrial Fibrillation.
The American journal of cardiology·2026
Transvalvular Flow Rate Is Associated With Mortality Rate and Lifetime Loss in Aortic Valve Stenosis: A Meta-Analysis of Reconstructed Time-to-Event Data.
The American journal of cardiology·2026
Identifying the Potential Role of Missense KIRREL3 Variants in Neurodevelopmental Phenotypes: A Case Series.
American journal of medical genetics. Part A·2026
Delineating the CTBP1-Related Phenotypic Spectrum: A Review of HADDTS and Atypical Variants.
International journal of molecular sciences·2026
Association Study Between NOTCH2 Gene and Idiopathic Central Precocious Puberty in Korean Girls.
International journal of molecular sciences·2026
Ultrasound-guided renal artery administration of angiopoietin-1 RNA therapy slows the progression of preclinical WT1 glomerular disease.
Science translational medicine·2026